Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
77.3M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
4.45M
-
Shares change
-
+175K
-
Total reported value, excl. options
-
$75.2M
-
Value change
-
+$2.92M
-
Number of buys
-
11
-
Number of sells
-
-6
-
Price
-
$16.86
Significant Holders of Xenon Pharmaceuticals Inc. - Common Stock (XENE) as of Q1 2015
24 filings reported holding XENE - Xenon Pharmaceuticals Inc. - Common Stock as of Q1 2015.
Xenon Pharmaceuticals Inc. - Common Stock (XENE) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.45M shares
of 77.3M outstanding shares and own 5.75% of the company stock.
Largest 10 shareholders include FMR LLC (1.26M shares), Capital World Investors (659K shares), Visium Asset Management, LP (475K shares), Invesco Private Capital, Inc. (445K shares), BVF INC/IL (391K shares), ROYAL BANK OF CANADA (330K shares), PERCEPTIVE ADVISORS LLC (225K shares), EcoR1 Capital, LLC (221K shares), Ativo Capital Management LLC (137K shares), and Novo A/S (128K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.